Back to RTW INVESTMENTS, LP RTW INVESTMENTS, LP

NBIXNBIX
5 quarters

Position history for RTW INVESTMENTS, LPRTW INVESTMENTS, LP's holdings in NEUROCRINE BIOSCIENCES INC

Yes. RTW Investments holds 1,267,925 shares of NBIX (Neurocrine Biosciences), worth $213.7M, as of its Q2 2026 13F filing. It increased the position by 205,853 shares (+19.4%) from Q1 2026. RTW Investments has held NBIX since Q2 2025, across 5 quarterly 13F filings. NBIX is 1.8% of RTW Investments' reported 13F portfolio.

Current Value

$213.7M

Current Shares

1.3M

Total Value Change

+$80.2M

Total Shares Change

+205,853

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+19.4%
$213.7M1.8%$168.54
57
2026-Q1
Unchanged
1.1M
0.0%
$139.9M1.4%$131.74
0
2025-Q4
Unchanged
1.1M
0.0%
$150.6M1.5%$141.83
0
2025-Q3
Unchanged
1.1M
0.0%
$149.1M1.8%$140.38
0
2025-Q2
New
1.1M
-
$133.5M1.9%$125.69
69

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used